Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    Rifabutin OR Mycobutin[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Unknown  Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
Conditions: Children With Confirmed HIV Infection;   Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose;   Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment
Intervention: Drug: Mycobutin
2 Unknown  EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
3 Recruiting Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly
Conditions: HIV;   Tuberculosis
Interventions: Drug: Lopinavir/r will be supplied by NHSO/GPO;   Drug: Rifabutin
4 Active, not recruiting Safety And Efficacy Of Rifabutin In HIV Patients
Conditions: Non-tuberculous Mycobacterial Diseases (Including MAC Disease);   Tuberculosis;   Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections
Intervention: Drug: rifabutin
5 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1;   Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2
6 Terminated
Has Results
Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults
Conditions: Staphylococcus Aureus;   HIV Infections
Interventions: Drug: rifabutin plus trimethoprim sulfamethoxazole;   Drug: placebo plus trimethoprim-sulfamethoxazole
7 Completed A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc
Conditions: HIV Infection;   HIV-1 Infection;   Mycobacterium Avium Complex (MAC)
Interventions: Drug: Rifabutin;   Drug: Maraviroc
8 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz;   Drug: rifabutin in combination with nevirapine;   Drug: rifabutin in combination with lopinavir/ritonavir
9 Completed TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Nelfinavir;   Drug: Rifabutin
10 Completed TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Isoniazid;   Drug: Rifabutin
11 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
12 Completed Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients
Conditions: Tuberculosis;   Non-tuberculous Mycobacterial Diseases (Including MAC Disease)
Intervention: Drug: rifabutin
13 Completed Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Rifabutin
14 Completed TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Rifabutin;   Drug: Efavirenz
15 Completed Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Rifampin;   Drug: Rifabutin
16 Completed A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
Conditions: Mycobacterium Avium-Intracellulare Infection;   HIV Infections
Intervention: Drug: Rifabutin
17 Completed Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
Conditions: Mycobacterium Avium-intracellulare Infection;   HIV Infections
Intervention: Drug: Rifabutin
18 Completed Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Rifabutin
19 Completed Drug-drug Interaction (DDI) Rifabutin
Condition: HIV/AIDS
Interventions: Drug: BMS-663068;   Drug: Rifabutin;   Drug: Ritonavir
20 Completed Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Conditions: Mycobacterium Avium-intracellulare Infection;   HIV Infections
Intervention: Drug: Rifabutin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.